• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

The Dawn of the Intelligence Age: How AI is Transforming Science and Medicine

user avatar

by Giorgi Kostiuk

2 years ago


On September 23, Sam Altman, co-founder and CEO of OpenAI, released an essay declaring the arrival of the “Intelligence Age.” Altman claims that AI will lead to exponential advancements including climate solutions and discoveries in physics. Despite criticism, AI is already being utilized in various scientific fields and medicine, accelerating research and improving healthcare services.

Artificial Intelligence in Ultrasound Imaging

GE Verisound AI employs proprietary software to assist non-experts in capturing high-quality ultrasound images of the heart, aiding in earlier disease detection. One of the company's main offerings, Caption AI, provides real-time visual guidance and quality measurement to ensure high-resolution images. The AutoEF feature, driven by AI algorithms, calculates critical heart health metrics such as the left ventricular ejection fraction.

AI in Drug Discovery

San Francisco-based Atomwise uses AI to accelerate the drug discovery process. Their AtomNet platform utilizes convolutional neural networks to predict the efficacy of potential drug candidates before costly clinical trials. By analyzing experimental affinity measurements and protein structures, AtomNet speeds up the identification of safe and effective drug candidates, significantly reducing the time and cost of bringing new medicines to market. In April 2024, Atomwise successfully identified novel drug candidates for 235 out of 318 targets.

The Role of AI in Radiology

Behold.ai is developing AI-assisted radiology with its “red dot” algorithm, which classifies chest X-rays and localizes findings as heat maps using deep learning models. The algorithm achieves 90% accuracy in detecting abnormalities within seconds, reducing radiologists' workloads and diagnosis wait times. Similarly, Enlitic uses deep learning to interpret medical images, enabling the detection of malignant lung nodules up to 18 months before a biopsy.

AI is playing a significant role in scientific research and medical advancements. Its applications, from ultrasound imaging to drug discovery and medical image interpretation, highlight its tremendous potential to improve healthcare and accelerate scientific progress.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

New Analysis Created Utilizing SEC Information.

chest

The report is based on information sourced from the SEC, providing stakeholders with accurate financial insights.

user avatarSatoshi Nakamura

Binance CEO Highlights Shift to Self-Hosted Wallets Amid EU Withdrawals

chest

Binance CEO Richard Teng revealed that 70% of the funds withdrawn by EU users went to self-hosted wallets instead of MiCA-regulated platforms.

user avatarFilippo Romano

Binance's Regulatory Challenges Continue as France Rejects License Application

chest

Binance faces regulatory challenges as its license application in France is rejected following the withdrawal of its MiCA application in Greece.

user avatarLucas Weissmann

Legal Battles Over Prediction Markets Escalate in the U.S.

chest

The legal landscape surrounding prediction markets in the U.S. is contentious, with the CFTC suing states to assert jurisdiction, leading to mixed court rulings and potential Supreme Court involvement.

user avatarJesper Sørensen

North Carolina Supports CFTC Authority Over Prediction Markets

chest

North Carolina has enacted a law recognizing CFTC authority over prediction markets, allowing them to operate legally with a 6% tax on revenue.

user avatarRajesh Kumar

Binance Withdraws MiCA License Application Amid Regulatory Challenges

chest

Binance withdrew its MiCA license application from Greek authorities, advising EU users to withdraw their funds due to regulatory delays and the approaching compliance deadline.

user avatarEmily Carter

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.